Valinor Discovery

Valinor Discovery

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://valinordiscovery.com

Last Round

Seed

Dec 16, 2025

Total Funding Raised

$13M

Momentum Score

50 /100

Company Overview

Valinor Discovery is a biotechnology company that provides an AI-powered platform to simulate drug responses before clinical trials using generative machine learning and patient-matched, longitudinal multi-omics data.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Medical AI, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Foundation

Keywords

virtual patientsgenerative AI platformdrug discoveryclinical trial simulationin silico trialsAI drug discoverypatient stratificationmulti-omics databiomarker discoverypredictive modelsdigital twinpatient response simulationcomputational biologypreclinical simulationno-code platformperturbation modelsoncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valinor Discovery Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Valinor Discovery Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedDec 16, 2025

Key People

Founding team and executive leadership

Zhanel Nugmanova

COO Co-Founder

Founding Team

Joshua Pacini

CEO Co-Founder

Founding Team

Valinor Discovery Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    Grew 21% QoQ from 14 to 17 employees.

  • Mar 2, 2026

    Combines machine learning capabilities with clinical laboratory infrastructure for multi-omics data generation.

Valinor Discovery Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valinor Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valinor Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range17
Year Founded2025
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.